Interferon Beta-1A
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00060 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 94 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | Jeune syndrome situs inversus | KG + DL |
| 2 | Pierre Robin syndrome associated with a chromosomal anomaly | KG + DL |
| 3 | partial deletion of the long arm of chromosome 22 | KG + DL |
| 4 | disorder of fucoglycosan synthesis | KG + DL |
| 5 | Laubry-Pezzi syndrome | KG + DL |
| 6 | partial deletion of the long arm of chromosome 7 | KG + DL |
| 7 | orofacial clefting syndrome | KG + DL |
| 8 | genetic syndromic Pierre Robin syndrome | KG + DL |
| 9 | rete ovarii cystadenoma | KG + DL |
| 10 | borderline ovarian serous tumor | KG + DL |
| 11 | ovarian benign neoplasm | KG + DL |
| 12 | ovarian papillary cystadenoma | KG + DL |
| 13 | ovarian mucinous cystadenofibroma | KG + DL |
| 14 | hairy cell leukemia | KG + DL |
| 15 | serous neoplasm | KG + DL |
| 16 | mucinous ovarian cystadenoma | KG + DL |
| 17 | malignant ovarian Brenner tumor | KG + DL |
| 18 | ovarian surface papilloma | KG + DL |
| 19 | autoimmune disease of central nervous system | KG + DL |
| 20 | mitral valve disease | KG + DL |
| 21 | pulmonary valve disease | KG + DL |
| 22 | CNS demyelinating autoimmune disease | KG + DL |
| 23 | interventricular septum aneurysm | KG + DL |
| 24 | multiple sclerosis, susceptibility to | KG + DL |
| 25 | mucinous ovarian cancer | KG + DL |
| 26 | hepatic infarction | KG + DL |
| 27 | fetal methylmercury syndrome | KG + DL |
| 28 | ovarian clear cell cancer | KG + DL |
| 29 | amyotrophic lateral sclerosis | KG + DL |
| 30 | heart neoplasm | KG + DL |
| 31 | aleukemic mast cell leukemia | KG + DL |
| 32 | peliosis hepatis | KG + DL |
| 33 | heart fibrosarcoma | KG + DL |
| 34 | heart disease | KG + DL |
| 35 | bilateral parasagittal parieto-occipital polymicrogyria | KG + DL |
| 36 | conventional fibrosarcoma | KG + DL |
| 37 | Mills syndrome | KG + DL |
| 38 | kidney fibrosarcoma | KG + DL |
| 39 | fibroblastic neoplasm | KG + DL |
| 40 | low grade fibromyxoid sarcoma | KG + DL |
| 41 | dermatofibrosarcoma protuberans | KG + DL |
| 42 | axial spondylometaphyseal dysplasia | KG + DL |
| 43 | pyelonephritis | KG + DL |
| 44 | amyotrophic lateral sclerosis, susceptibility to | KG + DL |
| 45 | hepatic veno-occlusive disease | KG + DL |
| 46 | ovarian epithelial tumor | KG + DL |
| 47 | syndrome with combined immunodeficiency | KG + DL |
| 48 | amyotrohpic lateral sclerosis type 22 | KG + DL |
| 49 | extramammary Paget disease | KG + DL |
| 50 | mucosal melanoma | KG + DL |
(Showing top 50 of 94 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.